The Worshipful Company of Spectacle Makers rewards early career research
The Worshipful Company of Spectacle Makers (WCSM) this week announced the winners of its annual bronze medal award competitions for vision research. Both the winning submissions demonstrated models for earlier diagnosis of significant eye disease and have the capacity to...
William’s Marathon Mission: Running for Sofie and Sight Scotland
William Oviatt is running the Edinburgh Marathon to raise money for Sight Scotland to say thank you for all the help and support the charity gave to his family when his daughter, Sofie, was diagnosed with retinal dystrophy.
The Retina International World Congress will take place in Dublin from June 5-8
The Retina International World Congress hosted by Fighting Blindness will take place in Dublin, Ireland, from June 5-8.
LambdaVision aims to refine process for in-space manufacturing of artificial retinas through ISS National Lab-sponsored investigation
Approximately 1.5 million people worldwide are affected by retinitis pigmentosa, a rare genetic disorder that causes vision loss. Currently there is no cure, but researchers from LambdaVision are turning to the International Space Station (ISS) National Laboratory to look for...
The Worshipful Company of Spectacle Makers awards 2023 Ruskell Medal for research
The Worshipful Company of Spectacle Makers has awarded its prestigious bronze Ruskell Medal for 2023 to Dr Cristina Martinez-Fernandez de la Camara, a senior scientist in the Clinical Ophthalmology Research Group at the Nuffield Department of Clinical Neurosciences at the University of Oxford, for her work on RPGR-associated retinal dystrophy.
Manchester Royal Eye Hospital first in UK to use ultra-wide field OCT angiography machine in patient facing setting
Manchester Royal Eye Hospital announces it is the first in the UK to utilise the ultra-wide field OCT angiography machine, the Xephilio OCT-S1 from Canon, in a patient facing setting.
Moorfields to start new retinal detachment clinical trial
Moorfields to start new retinal detachment clinical trial following £1.2 million MRC DPFS grant awarded to UCL and Moorfields Eye Hospital.
Optos announces new ultra-widefield colour image modality, providing additional retinal visualisation to eyecare professionals
Optos, Plc, the leading retinal imaging company, announces it is expanding the optomap® ultra-widefield (UWF™) retinal imaging modalities available with the California FA device to further assist eyecare professionals in disease management and treatment planning.
Kilt Walk Veteran says thank you to charity for life changing support
A veteran has led his ‘Daredevils’ team on a 22.7 mile walk to say thank-you to Sight Scotland Veterans for all the life changing support they provide.